Stone Sentinel Capital · Q1 2025 · Published 9 April 2025 · Quarterly letter
Q1 2025 Letter to Partners: Insist on the Most Knowable
Marcel Gozali argues that an investor should buy only stocks that can be known and that rise in many versions of the future, such as Grupo Empresarial San José, whose net cash about equals its €370 million market value.
Summary
Marcel Gozali reports that Stone Sentinel Capital made 14.4% in the first quarter of 2025, while the S&P 500 lost 4.3%. He argues for insisting on the most knowable stocks, those that would rise in the widest range of futures, and for waiting when none is found. Drawing on James Carse's Finite and Infinite Games, he argues that an investor beats the market by not aiming at it. Grupo Empresarial San José and Claranova added most to returns and Collegium Pharmaceutical cost the most.
Key insights
- Stone Sentinel Capital made 14.4% gross in the first quarter of 2025 and 29.8% in 2024, against -4.3% and 25.0% for the S&P 500.
- Gozali has 99% of his net worth invested in Stone Sentinel Capital.
- Grupo Empresarial San José's price about equals its cash net of debt, while its construction business earns €116 million of trailing free cash flow and its CEO owns 50%.
- Claranova trades at 3-5x trailing free cash flow, and its most profitable segment grew EBITDA 42% a year for three years.
- Gozali reports that Collegium Pharmaceutical replaced the CEO who had done every acquisition, and that its founder-chairman was also replaced.
- He calculates that the S&P 500's falls of about 5% and 6% on consecutive days after 4 April 2025 had odds of about 1 in 3.3 quadrillion.
Companies discussed
More